Alere Triage® TOX Drug Screen Control 1 Product Generic Name: Quality Control Material Description of the product: Good Laboratory Practice suggests that external controls should be tested with each new lot or shipment of test materials, or every 30 days, and as otherwise required by a laboratorys standard quality control procedures. The Alere Triage® Drug Screen Controls, when used in accordance with the test procedures described in the Alere Triage® TOX Drug Screen package insert, provide this capability. The results obtained for the controls are to be compared with the assigned values given on the Expected Values Card, accompanying the package insert, to determine if the procedure is within control limits. Alere Triage® TOX Drug Screen Control 1 or Alere Triage® TOX Drug Screen Control 2 consist of human urine matrix containing parent compounds and/or major metabolites/analogues of drugs of abuse. 510(k)/IDE/PMA number: K060788 Type of Packaging: 5 vials per level in a labeled kit box. Indications for use: The Alere Triage® TOX Drug Screen Controls are to be used with the Alere Triage® TOX Drug Screen tests and Alere Triage® Meters to assist the laboratory in monitoring test performance.
Publicado el 30 de octubre de 2013 · Inicio del retiro: 23 de septiembre de 2013
Resumen
FDA registra el retiro Z-0053-2014 de dispositivos médicos de Clase III, publicado el 30 de octubre de 2013 e iniciado el 23 de septiembre de 2013. Empresa responsable: Alere San Diego, Inc.; Estado: Finalizado; Cantidad reportada: 38; Lote: Part Number 94413. Lot Number C2681A. La Clase III indica que no es probable que el producto cause consecuencias adversas para la salud.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Alere San Diego, Inc. initiated a voluntary recall of Alere Triage TOX Drug Screen Control 1 (PN 94413, Lot C2681A) because the CODE CHIP that was provided with this lot causes the control to fail when run in the QC Sample Mode using Alere Triage TOX Drug Screeen products. The Alere Triage TOX Drug Screen test devices and patient results are not affected.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Alere San Diego, Inc.
- Distribuidor
- Worldwide Distribution - USA (nationwide) and countries of: South Africa and Canada.
- Lote
- Part Number 94413. Lot Number C2681A.
- Clasificación de riesgo
- Class III
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAMcKesson CONSULT hCG Urine Cassette, Model/ Part: FHC-A102/5001; Alere hCG Cassette (20 mIU/mL) in Urine,7 de octubre de 2026
- FDAFisher Scientific Sure-Vue Urine hCG Strip, Model/ Part: FHC-101/23900527; McKesson CONSULT hCG Urine Test7 de octubre de 2026
- FDAFisher Scientific Sure-Vue Urine hCG, Model/ Part: FHC-102/23900526; Henry Schein, Inc. One Step + Urine7 de octubre de 2026
- FDAFisher Scientific Sure-Vue Serum/Urine hCG, Model/ Part: FHC-202/23900529, FHC-202/23900528; Beckman Coulter7 de octubre de 2026
- FDAAcuson SC2000 volume imaging ultrasound systems at software version 3.0. Mfg name: Siemens Medical Solutions30 de octubre de 2013
- FDAIntegra Licox Brain Tissue Oxygen Monitoring; 1 x Complete Brain Probe Kit REF IP1.P Rx Only, Manufacturer30 de octubre de 2013
Preguntas sobre este retiro
¿Alere Triage® TOX Drug Screen Control 1 Product Generic Name: Quality Control Material Description of the product: Good Laboratory Practice suggests that external controls should be tested with each new lot or shipment of test materials, or every 30 days, and as otherwise required by a laboratorys standard quality control procedures. The Alere Triage® Drug Screen Controls, when used in accordance with the test procedures described in the Alere Triage® TOX Drug Screen package insert, provide this capability. The results obtained for the controls are to be compared with the assigned values given on the Expected Values Card, accompanying the package insert, to determine if the procedure is within control limits. Alere Triage® TOX Drug Screen Control 1 or Alere Triage® TOX Drug Screen Control 2 consist of human urine matrix containing parent compounds and/or major metabolites/analogues of drugs of abuse. 510(k)/IDE/PMA number: K060788 Type of Packaging: 5 vials per level in a labeled kit box. Indications for use: The Alere Triage® TOX Drug Screen Controls are to be used with the Alere Triage® TOX Drug Screen tests and Alere Triage® Meters to assist the laboratory in monitoring test performance. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0053-2014 el 30 de octubre de 2013. Peligro reportado: Alere San Diego, Inc. initiated a voluntary recall of Alere Triage TOX Drug Screen Control 1 (PN 94413, Lot C2681A) because the CODE CHIP that was provided with this lot causes the control to fail when run in the QC Sample Mode using Alere Triage TOX Drug Screeen products. The Alere Triage TOX Drug Screen test devices and patient results are not affected.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit